Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC

NCT05505175 · clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer